Target intelligence / Profile preview

Bacterial and fungal cell membranes and cell walls

Molecular classification
Structural component, Cellular barrier, Enzyme (as target of synthesis inhibitors), Other
01

Overview

The bacterial and fungal cell membranes and cell walls are essential structural components that provide mechanical strength, maintain osmotic pressure, and regulate the transport of molecules (StatPearls, 2023). In bacteria, the cell wall is primarily composed of peptidoglycan, which is targeted by beta-lactam antibiotics to induce cell lysis, while the cell membrane is targeted by lipopeptides like daptomycin (NIH, 2022). Fungal cells possess a unique cell wall containing chitin and beta-glucans, and a cell membrane characterized by the presence of ergosterol instead of cholesterol (NCBI, 2021). These structures are critical for microbial survival and are absent in human cells, making them ideal targets for selective toxicity in treating infectious diseases (PubMed, 2023). Drugs targeting these barriers either inhibit the enzymatic synthesis of structural polymers or directly disrupt the physical integrity of the lipid bilayer (Merck Manual, 2023). However, the clinical utility of these targets is frequently challenged by the emergence of multi-drug resistant organisms and potential host toxicities associated with certain membrane-disrupting agents.

Other names
Microbial cell envelopeBacterial cell wallFungal cell wallCytoplasmic membranePeptidoglycan layerErgosterol-containing membrane
02

Mechanism of action

Inhibition of peptidoglycan synthesis and cross-linking, inhibition of 1,3-beta-D-glucan synthesis, disruption of membrane integrity through pore formation or depolarization, and inhibition of ergosterol biosynthesis.

03

Biological functions

Structural integrityOsmotic protectionSelective permeabilityCell divisionProtection from environmental stressSignal transduction
04

Disease associations

InfectionBacterial infectionFungal infection (Mycosis)SepsisCandidiasisAspergillosis
05

Safety considerations

NephrotoxicityNeurotoxicityInfusion-related reactionsHepatotoxicityDisruption of commensal microbiomeDevelopment of antimicrobial resistance (AMR)
06

Interacting drugs

Penicillin G

9 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)(1,3)-beta-D-glucan assayGalactomannan assayProcalcitoninC-reactive protein (CRP)

Beyond the preview

Go deeper on Bacterial and fungal cell membranes and cell walls.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial and fungal cell membranes and cell walls.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call